My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Hematología, Inmunología y Hemoterapia
Print version ISSN 0864-0289On-line version ISSN 1561-2996
Abstract
DIAZ DOMINGUEZ, Gabriela; CASADO HERNANDEZ, Imilla; MARSAN SUAREZ, Vianed and MACIAS ABRAHAM, Consuelo M.. Advances in the diagnosis of chronic granulomatous disease: the first family study in Cuba. Rev Cubana Hematol Inmunol Hemoter [online]. 2020, vol.36, n.2, e1102. Epub Oct 01, 2020. ISSN 0864-0289.
Introduction:
Chronic granulomatous disease is a primary immunodeficiency caused by mutations in the NADPH oxidase enzymes. This compromises the production of oxygen reactive species, which are important against pathogens. The dihydrorhodamine oxidation test is an effective method for diagnosing the disease.
Objective:
To demonstrate the usefulness of the dihydrorhodamine oxidation test and the inheritance pattern in confirming the diagnosis of chronic granulomatous disease in a patient.
Methods:
A case study of a family with a diagnosis of chronic granulomatous disease. A peripheral blood sample was taken from three individuals and by flow cytometry. The dihydrorhodamine oxidation test was performed under stimulation with phorbolmyristate acetate, and lymphocyte subpopulations were evaluated. The samples were read on a GALLIOS, Beckman Coulter cytometer. The data obtained were analyzed using the computer program Kaluza.
Results:
The male patient had a positive dihydrorhodamine oxidation value of 0.87%, which confirmed an inheritance pattern linked to the X chromosome; while the carrier mother and twin sister had values of 46.76% and 37.32%, respectively. Alterations were found in the lymphocyte subpopulations.
Conclusions:
The dihydrorhodamine oxidation test is a very effective, fast and simple method that confirms the diagnosis of chronic granulomatous disease and determines the inheritance pattern and phenotype of the disease. In addition, it allows the identification of female carriers according to the distribution of normal neutrophils and those with the CYBB mutation.
Keywords : chronic granulomatous disease; dihydrorhodamine oxidation test; flow cytometry.